Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Foundation Fighting Blindness Stories

2007-06-04 12:00:42

Copernicus Therapeutics, Inc. announced today that a research team at University of Oklahoma Health Sciences Center, led by Dr. Muna Naash, Professor of Cell Biology, demonstrated that Copernicus' DNA nanoparticles corrected vision defects in a mouse model of retinitis pigmentosa (RP). These findings were presented at the American Society of Gene Therapy meeting in Seattle, WA. Mutations in genes important in the biology of vision cause RP, a common genetic form of visual impairment...

2005-08-03 15:09:44

GAINESVILLE, Fla. - University of Florida scientists used a healthy human gene to prevent blindness in mice with a form of an incurable eye disease that strikes boys. Writing in the August issue of Molecular Therapy, scientists from the UF Genetics Institute describe how they successfully used gene therapy in mice to treat retinoschisis, a rare genetic disorder that is passed from mothers, who retain their sight, to their sons. "Currently there is no treatment," said William Hauswirth,...

2004-11-25 15:00:08

Moran Eye Center researchers have found gene mutations that result in retinitis pigmentosa (RP), one of the leading causes of blindness. The discovery has raised fears that medications commonly used to treat both heart disease and glaucoma may trigger the eye disease in even those without the mutation because of similarities in what the mutations and the drugs do to the eyes. The research, published in the online version of Human Molecular Genetics Wednesday, says each gene mutation...